Literature DB >> 15773799

[Drug use in a neonatal ICU: a prospective study].

R López Martínez1, M J Cabañas Poy, M Oliveras Arenas, S Clemente Bautista.   

Abstract

INTRODUCTION: Many drugs prescribed in pediatric units do not meet the conditions of use defined in their corresponding prescription information sheets, or their use has not been approved by the Spanish Health Authorities. The lack of clinical trials in children, and of adequate dosage forms, reduces drug safety, assuming both the physician and the pharmacist the responsibility for the drug use.
OBJECTIVE: To assess drug prescription status within a neonatal intensive care unit in a third-level hospital.
MATERIAL AND METHODS: A 3-months prospective study was performed, and information was collected from all admitted children along four time periods. Sixty-one complete therapies were evaluated, with a total of 236 drugs prescribed. Fifty percent were off-label, 13% were unlicensed, and 37% were correctly used.
CONCLUSIONS: These figures resemble those from, similar studies carried out in other European hospitals. This is therefore a common practice resulting from the need to treat. Health authorities should encourage clinical trials so that drug therapies for children become evidence-based.

Entities:  

Mesh:

Year:  2005        PMID: 15773799     DOI: 10.1016/s1130-6343(05)73632-1

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  9 in total

1.  Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.

Authors:  Laura Cuzzolin; Rocco Agostino
Journal:  Eur J Clin Pharmacol       Date:  2016-01       Impact factor: 2.953

Review 2.  Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.

Authors:  Joana Magalhães; António Teixeira Rodrigues; Fátima Roque; Adolfo Figueiras; Amílcar Falcão; Maria Teresa Herdeiro
Journal:  Eur J Clin Pharmacol       Date:  2014-10-16       Impact factor: 2.953

3.  Unlicensed and Off-Label Drug Use in Children Before and After Pediatric Governmental Initiatives.

Authors:  Jennifer Corny; Denis Lebel; Benoit Bailey; Jean-François Bussières
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

4.  Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital.

Authors:  Jennifer Corny; Benoit Bailey; Denis Lebel; Jean-François Bussières
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

5.  Pharmacotherapy in pediatric critical illness: a prospective observational study.

Authors:  Conor McDonnell; Stanley Hum; Helena Frndova; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Magistral drugs in hospitalized newborns and children.

Authors:  Agueda Cabral de Souza Pereira; Elaine Silva Miranda; Selma Rodrigues de Castilho; Débora Omena Futuro; Lenise Arneiro Teixeira; Geraldo Renato de Paula
Journal:  Rev Paul Pediatr       Date:  2016-03-28

7.  Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing.

Authors:  Muhammad Aamir; Jamshaid Ali Khan; Faisal Shakeel; Rabeea Shareef; Nazia Shah
Journal:  BMC Pediatr       Date:  2018-07-25       Impact factor: 2.125

8.  Medication follow-up in newborns with extremely low birth-weight.

Authors:  Catarine V Loureiro; Marta M Fonteles; Mylenne B Mascarenhas; Elana F Chaves; Paulo Y Firmino
Journal:  Pharm Pract (Granada)       Date:  2019-11-20

Review 9.  Review of Drug Utilization Studies in Neonatal Units: A Global Perspective.

Authors:  Asma Al-Turkait; Lisa Szatkowski; Imti Choonara; Shalini Ojha
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.